Diagnostics and management approaches for Acanthamoeba keratitis

References

• Seal DV. Acanthamoeba keratitis update – incidence, molecular epidemiology and new drugs for treatment. Eye (Lond). 2003;17:893–905.
   PubMed Web of Science ®Google Scholar
• Green M, Carnt N, Apel A, et al. Queensland microbial keratitis database: 2005-2015. Br J Ophthalmol. 2019;103:1481–1486.
   PubMed Web of Science ®Google Scholar
• McKelvie J, Alshiakhi M, Ziaei M, et al. The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016). Clin Exp Ophthalmol. 2018;46:600–607.
   PubMed Web of Science ®Google Scholar
• Nielsen SE, Ivarsen A, Hjordtal J. Increasing incidence of Acanthamoeba keratitis in a large tertiary ophthalmology department from 1994 to 2018. Acta Ophthalmol Dec. 2019;29. [Epub ahead of print]. DOI:10.1111/aos.14337
   Google Scholar
• Neelam S, Niederkorn JY. Pathobiology and Immunobiology of acanthamoeba keratitis: insights from animal models. Yale J Biol Med. 2017;90:261–268.
   PubMed Web of Science ®Google Scholar
• Daas L, Szentmáry N, Eppig T, et al. The German acanthamoeba keratitis register: initial results of a multicenter study. Ophthalmologe. 2015;112:752–753.
   PubMed Web of Science ®Google Scholar
• Meltendorf C, Duncker G. Acanthamoeba keratitis. Klin Monatsbl Augenheilkd. 2011;228:R29–R43.
   PubMed Web of Science ®Google Scholar
• Szentmáry N, Goebels S, Matoula P, et al. Acanthamoeba keratitis – a rare and often late diagnosed disease. Klin Monbl Augenheilkd. 2012;229:521–528.
   PubMed Web of Science ®Google Scholar
• Shi L, Hager T, Fries FN, et al. Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of Acanthamoeba keratitis: a histological study. Int J Ophthalmol. 2019;12:1966–1971.
   PubMed Web of Science ®Google Scholar
• Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009;148:487–499.
   PubMed Web of Science ®Google Scholar
• Daas L, Viestenz A, Schnabel P, et al. Confocal microscopy in Acanthamoeba keratitis as an early relapse-marker. Clin Anat. 2018;31:60–63.
   PubMed Web of Science ®Google Scholar
• Pfister DR, Cameron JD, Krachmer JH, et al. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol. 1996;121:119–128.
   PubMed Web of Science ®Google Scholar
• Palusinska-Szysz M, Kania M, Turska-Szewczuk A, et al. Identification of unusual phospholipid fatty acyl compositions of Acanthamoeba castellanii. PLoS One. 2014;9:e101243. Published 2014 Jul 9.
   PubMed Web of Science ®Google Scholar
• Maschio VJ, Virginio VG, Ferreira HB, et al. Comparative proteomic analysis of soluble and surface-enriched proteins from Acanthamoeba castellanii trophozoites. Mol Biochem Parasitol. 2018;225:47–53.
   PubMed Web of Science ®Google Scholar
• Del Chierico F, Di Cave D, Accardi C, et al. Identification and typing of free-living Acanthamoeba spp. by MALDI-TOF MS Biotyper. Exp Parasitol. 2016;170:82–89.
   PubMed Web of Science ®Google Scholar
• Duguid IG, Dart JK, Morlet N, et al. Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997;104:1587–1592.
   PubMed Web of Science ®Google Scholar
• Lehmann OJ, Green SM, Morlet N, et al. Polymerase chain reaction analysis of corneal epithelial and tear samples in the diagnosis of Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998;39:1261–1265.
   PubMed Web of Science ®Google Scholar
• Qvarnstrom Y, Visvesvara GS, Sriram R, et al. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol. 2006;44:3589–3595.
   PubMed Web of Science ®Google Scholar
• Thompson PP, Kowalski RP, Shanks RM, et al. Validation of real-time PCR for laboratory diagnosis of Acanthamoeba keratitis. J Clin Microbiol. 2008;46:3232–3236.
   PubMed Web of Science ®Google Scholar
• Mathers WD, Sutphin JE, Folberg R, et al. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol. 1996;121:129–142.
   PubMed Web of Science ®Google Scholar
• Reinhard T, Behrens-Baumann W. Anti-infective drug therapy in ophthalmology – part 4: acanthamoeba keratitis. Klin Monatsbl Augenheilkd. 2006;223:485–491.
   PubMed Web of Science ®Google Scholar
• Aspöck H. Grundzüge der Diagnostik. In: Hiepe T, Lucius R, Gottstein B, editors. Allgemeine Parasitologie mit den Grundzügen der Immunologie, Diagnostik und Bekämpfung. Stuttgart: Parey in MVS Medizinverlage; 2006. p. 339–457.
   Google Scholar
• Bacon AS, Frazer DG, Dart JK, et al. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye. 1993;7:719–725.
   PubMed Web of Science ®Google Scholar
• Sharma S, Athmanathan S, Atha-Ur-Rasheed M, et al. Evaluation of immunoperoxidase staining technique in the diagnosis of Acanthamoeba keratitis. Indian J Ophthalmol. 2001;49:181–186.
   PubMedGoogle Scholar
• Claerhout I, Goegebuer A, Van Den Broecke C, et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:648–653.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feng X, Jiang L. Current advances in diagnostic methods of Acanthamoeba keratitis. Chin Med J (Engl). 2014;127:3165–3170.
   PubMed Web of Science ®Google Scholar
• Tu EY, Joslin CE. Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. Eye (Lond). 2012;26:222–227.
   PubMed Web of Science ®Google Scholar
• Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003;16:273–307.
   PubMed Web of Science ®Google Scholar
• Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev. 2006;30:564–595.
   PubMed Web of Science ®Google Scholar
• Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10–?.
   PubMedGoogle Scholar
• Khan NA, Anwar A, Siddiqui R. Acanthamoeba keratitis: current status and urgent research priorities. Curr Med Chem. 2019;26:5711–5726.
   PubMed Web of Science ®Google Scholar
• Siddiqui R, Aqeel Y, Khan NA. The development of drugs against Acanthamoeba infections. Antimicrob Agents Chemother. 2016;60:6441–6450.
   PubMed Web of Science ®Google Scholar
• Szentmáry N, Daas L, Matoula P, et al. Akanthamöbenkeratitis. Ophthalmologe. 2013;110:1203–1210.
   PubMed Web of Science ®Google Scholar
• Szentmáry N, Daas L, Shi L, et al. SOP Akanthamöbenkeratitis – klinische Zeichen, Diagnose, Therapie. Klin Monbl Augenheilkd. 2018;235:671–677.
   Google Scholar
• Szentmáry N, Daas L, Shi L, et al. Acanthamoeba keratitis - Clinical signs, differential diagnosis and treatment. J Curr Ophthalmol. 2018;31:16–23.
   PubMed Web of Science ®Google Scholar
• Kim S, Chen J, Cheng T, et al. Pubchem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019;47:D 1102–9.
   Web of Science ®Google Scholar
• Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992;99:185–191.
   PubMed Web of Science ®Google Scholar
• Ficker L, Seal D, Warhurst D, et al. Acanthamoeba keratitis – resistance to medical therapy. Eye (Lond). 1990;4(Pt 6):835–838.
   PubMedGoogle Scholar
• Á O, Belloc J, Rubio E, et al. In-vitro development of an effective treatment for Acanthamoeba keratitis. Int J Antimicrob Agents. 2017;50:325–333.
   PubMed Web of Science ®Google Scholar
• Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol. 1985;69:778–821.
   PubMed Web of Science ®Google Scholar
• Shi L, Stachon T, Seitz B, et al. The effect of antiamoebic agents on viability, proliferation and migration of human epithelial cells, keratocytes and endothelial cells, in vitro. Curr Eye Res. 2018;43:725–733.
   PubMed Web of Science ®Google Scholar
• Elder MJ, Kilvington S, Dart JK. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1994;35:1059–1064.
   PubMed Web of Science ®Google Scholar
• Sunada A, Kimura K, Nishi K, et al. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Ophthalmology. 2014;121:2059–2065.
   PubMed Web of Science ®Google Scholar
• Polat ZA, Walochnik J, Obwaller A, et al. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis. Clin Exp Ophthalmol. 2014;42:151–158.
   PubMed Web of Science ®Google Scholar
• McClellan K, Howard K, Niederkorn JY, et al. Effect of steroids on Acanthamoeba cysts and trophozoites. Invest Ophthalmol Vis Sci. 2001;42:85–2893.
   Web of Science ®Google Scholar
• Carnt N, Optom B, Robaei D, et al. The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of Acanthamoeba keratitis. Ophthalmology. 2016;123:984–990.
   PubMed Web of Science ®Google Scholar
• D`Aversa G, Stern GA, Driebe Jr. WT. Diagnosis and successful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol. 1995;113:1120–1123.
   PubMedGoogle Scholar
• Amoils SP, Heney C. Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. Am J Ophthalmol. 1999;127:718–720.
   PubMed Web of Science ®Google Scholar
• Agahan AL, Lim RB, Valenton MJ. Successful treatment of Acanthamoeba keratitis without anti-amoebic agents. Ann Acad Med Singapore. 2009;38:175–176.
   PubMed Web of Science ®Google Scholar
• Neelam S, Niederkorn JY. Pathobiology and immunobiology of Acanthamoeba keratitis: insights from animal models microbes infect. Yale J Biol Med. 2017;90:261–268.
   PubMed Web of Science ®Google Scholar
• McClellan K, Howard K, Mayhew E, et al. Adaptive immune responses to Acanthamoeba cysts. Exp Eye Res. 2002;75:285–293.
   PubMed Web of Science ®Google Scholar
• Awwad ST, Heilman M, Hogan RN, et al. Severe reactive ischemic posterior segment inflammation in Acanthamoeba keratitis. Ophthalmology. 2007;114:313–320.
   PubMed Web of Science ®Google Scholar
• Burke JP, Webber SK, Kerr-Muir MG, et al. Acanthamoeba polyphaga panophthalmitis. Cornea. 1992;11:274–275.
   PubMed Web of Science ®Google Scholar
• Lee GA, Gray TB, Dart JK, et al. Acanthamoeba sclerokeratitis. Treatment with systemic immunosuppression. Ophthalmology. 2002;109:1178–1182.
   PubMed Web of Science ®Google Scholar
• Johns KJ, O’Day DM, Feman SS. Chorioretinitis in the contralateral eye of a patient with Acanthamoeba keratitis. Ophthalmology. 1988;95:635–639.
   PubMed Web of Science ®Google Scholar
• Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc UK. 1975;95:221–232.
   PubMedGoogle Scholar
• Heffler KF, Eckhardt TJ, Reboli AC, et al. Acanthamoeba endophthalmitis in acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;122:584–586.
   PubMed Web of Science ®Google Scholar
• Moshari A, McLean IW, Dodds MT, et al. Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. Ophthalmology. 2001;108:2232–2236.
   PubMed Web of Science ®Google Scholar
• Mammo Z, Almeida DR, Cunningham MA, et al. Acanthamoeba endophthalmitis after recurrent keratitis and nodular scleritis. Retin Cases Brief Rep. 2017;11:180–182.
   PubMedGoogle Scholar
• Clarke DW, Alizaden H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci. 2005;46:2472–2478.
   PubMed Web of Science ®Google Scholar
• Ehlers N, Hjortdal J. Are cataract and iris atrophy toxic complications of medical treatment of Acanthamoeba keratitis? Acta Ophthalmol Scand. 2004;82:228–231.
   PubMed Web of Science ®Google Scholar
• Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology. 2008;115:866–869.
   PubMed Web of Science ®Google Scholar
• Brooks Jr. JG, Coster DJ, Badenoch PR. Acanthamoeba keratitis. Resolution after epithelial debridement. Cornea. 1994;13:186–189.
   PubMed Web of Science ®Google Scholar
• Klüppel M, Reinhard T, Sundmacher R, et al. Therapy of advanced amoeba keratitis with keratoplasty à chaud and adjuvant cryotherapy. Ophthalmologe. 1997;94:99–103.
   PubMed Web of Science ®Google Scholar
• Szentmáry N, Goebels S, Bischoff M, et al. [Photodynamic therapy (PDT) for infectious keratitis]. Ophthalmologe. 2012;109:165–170.
   PubMed Web of Science ®Google Scholar
• Khan YA, Kashiwabuchi RT, Martins SA, et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeben keratitis: report of 3 cases. Ophthalmology. 2011;118:324–331.
   PubMed Web of Science ®Google Scholar
• Hager T, Hasenfus A, Stachon T, et al. Crosslinking and corneal cryotherapy in Acanthamoeba keratitis - a histological study. Graefes Arch Clin Exp Ophthalmol 254, 149-53 (2016).
   Google Scholar
• Laurik KL, Szentmáry N, Daas L, et al. Early penetrating keratoplasty à chaud may improve outcome in therapy-resistant Acanthamoeba keratitis. Adv Ther. 2019;36:2528–2540.
   PubMed Web of Science ®Google Scholar
• Seitz B, Resch MD, Schlötzer-Schrehardt U, et al. Histopathology and ultrastructure of human corneas after amniotic membrane transplantation. Arch Ophthalmol. 2006;124:1487–1490
   PubMedGoogle Scholar
• Seitz B, Langenbucher A, Kus MM, et al. Nonmechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty. Ophthalmology. 1999;106:1556–1564.
   Web of Science ®Google Scholar
• Szentmáry N, Langenbucher A, Kus MM, et al. Elliptical nonmechanical corneal trephination - Intraoperative complications and long-term outcome of 42 consecutive penetrating keratoplasties. Cornea. 2007;26:414–420.
   PubMed Web of Science ®Google Scholar
• Szentmáry N, Langenbucher A, Kus MM, et al. Long-term refractive results of elliptical excimer laser penetrating keratoplasty (EELPK). Curr Eye Res. 2007;32:953–959.
   PubMed Web of Science ®Google Scholar
• Seitz B, Daas L, Milioti G, et al. [Excimer laser-assisted penetrating keratoplasty: on 1 July 2019 excimer laser penetrating keratoplasty celebrates its 30th anniversary. Video article]. Ophthalmologe. 2019;116:1221–1230.
   PubMed Web of Science ®Google Scholar
• Robaei D, Carnt N, Minassian DC, et al. Therapeutic and optical keratoplasty in the management of Acanthamoeba keratitis: risk factors, outcomes, and summary of the literature. Ophthalmology. 2015;122:17–24.
   PubMed Web of Science ®Google Scholar
• Iovieno A, Gore DM, Carnt N, et al. Acanthamoeba sclerokeratitis: epidemiology, clinical features and treatment outcomes. Ophthalmology. 2014;121:2340–2347.
   PubMed Web of Science ®Google Scholar